Timing of adverse events during maintenance treatment with rucaparib for recurrent ovarian cancer in the phase III ARIEL3 study Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Dean, A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Colombo, N.; Weberpals, J.; Clamp, A. R.; Scambia, G.; Leary, A.; Holloway, R. W.; Amenedo Gancedo, M.; Fong, P. C.; Goh, J. C.; O'Malley, D. M.; Cameron, T.; Maloney, L.; Goble, S.; Coleman, R. L.; Ledermann, J. A.

authors

Publication Date

  • September 1, 2020

webpage

published in

category

start page

  • S620

end page

  • S621

volume

  • 31